← Back to the fund pageUse your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict
Mirae Asset ELSS Tax Saver Fund
Direct Plan · Growth · ELSS (Tax Saving) · Scheme code 135781
NAV₹58.3290as on 28 Aug 2026
Fund houseMirae Asset Mutual Fund
CategoryELSS (Tax Saving)
Plan & optionDirect · Growth
History10.7 years
Returns (%)
1M
3M
6M
1Y
3Y
5Y
7Y
10Y
Launch
This scheme
1.00
5.51
3.26
7.53
14.26
12.69
18.30
17.34
17.95
Nifty 500 benchmark
0.87
4.31
2.15
5.20
12.49
11.41
—
—
15.49
ELSS (Tax Saving) category median
—
—
—
3.06
13.90
13.17
—
13.83
—
Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
16.1%
0.48
0.66
1.00
2.99%
-37.8%
97.74
Nifty 500 benchmark
17.2%
0.35
0.47
—
—
-37.3%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
83 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
476
-20.3%
15.2%
113.3%
10%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
InvestVerdict
Mirae Asset ELSS Tax Saver Fund
Direct Plan · Growth
Allocation
By asset
Equity
99.12%
Cash & Equivalents
0.88%
By market cap
Large Cap
55.82%
Mid Cap
22.17%
Small Cap
21.12%
Concentration
Number of stocks
67
Top 5 stocks
27.45%
Top 10 stocks
40.54%
Top 20 stocks
60.95%
Largest holding
9.56%
Largest sector
Banks 26.13%
Effective stocks
34.4
Cash
0.88%
InvestVerdict
Mirae Asset ELSS Tax Saver Fund
Direct Plan · Growth · holdings
Top 18 holdings
#
Company
Sector
% of fund
1
—
Banks
9.56%
2
—
Banks
5.11%
3
—
Petroleum Products
4.67%
4
—
Banks
4.16%
5
—
Pharmaceuticals & Biotechnology
3.96%
6
—
Banks
3.12%
7
—
Financial Technology (Fintech)
2.56%
8
—
Telecom - Services
2.53%
9
—
Diversified FMCG
2.48%
10
—
Transport Services
2.41%
11
—
Pharmaceuticals & Biotechnology
2.35%
12
—
Consumer Durables
2.29%
13
—
IT - Software
2.21%
14
—
Telecom - Services
2.14%
15
—
Insurance
2.03%
16
—
Banks
2.02%
17
—
Retailing
1.93%
18
—
Realty
1.84%
Sector split
Banks
26.13%
Pharmaceuticals & Biotechnology
9.09%
Petroleum Products
5.67%
Retailing
5.59%
Consumer Durables
4.86%
Insurance
4.74%
Automobiles
4.71%
Telecom - Services
4.67%
IT - Software
4.11%
Transport Services
4.02%
A ₹10,000 monthly SIP over five years
Invested
Value
Gain
XIRR
₹600,000
₹830,330
₹230,330
12.97%
XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has
been invested for a different length of time.
Not investment advice. InvestVerdict is not a SEBI-registered Investment
Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 30 Aug 2026.